Corbus Pharmaceuticals Holdings Inc (CRBP)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Share on 𝕏

Cours de l'action
Code mnémonique : CRBP Marché : NMS


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette
90 derniers jours
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur totale Détails
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
8 862 +0.4%
45,96
407 298 USD 		8 862 +0.4% 45,96 407 298 USD
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
156 597 +8.4%
45,26
7 087 580 USD 		156 597 +8.4% 45,26 7 087 580 USD
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
61 668 +3.4%
44,62
2 751 626 USD 		61 668 +3.4% 44,62 2 751 626 USD
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
18 548 +1.0%
43,26
802 386 USD 		18 548 +1.0% 43,26 802 386 USD
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
24 983 +1.4%
42,25
1 055 532 USD 		24 983 +1.4% 42,25 1 055 532 USD
2024-03-11 2024-03-08 A Achat

Cormorant Asset Management, LP

Actionnaire important
29 342 +1.7%
41,23
1 209 771 USD 		29 342 +1.7% 41,23 1 209 771 USD
2024-03-11 2024-03-07 A Achat

Cormorant Asset Management, LP

Actionnaire important
102 140 +6.3%
41,23
4 211 232 USD 		102 140 +6.3% 41,23 4 211 232 USD
2024-03-11 2024-03-07 A Achat

Cormorant Asset Management, LP

Actionnaire important
90 325 +5.9%
39,99
3 612 097 USD 		90 325 +5.9% 39,99 3 612 097 USD
2024-03-11 2024-03-07 A Achat

Cormorant Asset Management, LP

Actionnaire important
10 736 +0.7%
39,13
420 100 USD 		10 736 +0.7% 39,13 420 100 USD
2024-03-11 2024-03-07 A Achat

Cormorant Asset Management, LP

Actionnaire important
46 799 +3.2%
37,82
1 769 938 USD 		46 799 +3.2% 37,82 1 769 938 USD
2024-02-06 2024-02-02 A Achat

Cormorant Asset Management, LP

Actionnaire important
750 000 +103.4%
19,00
14 250 000 USD 		750 000 +103.4% 19,00 14 250 000 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
3 200 +0.4%
38,49
123 168 USD 		3 200 +0.4% 38,49 123 168 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
43 754 +6.5%
37,49
1 640 337 USD 		43 754 +6.5% 37,49 1 640 337 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
16 484 +2.5%
36,53
602 161 USD 		16 484 +2.5% 36,53 602 161 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
32 295 +5.1%
35,83
1 157 130 USD 		32 295 +5.1% 35,83 1 157 130 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
31 549 +5.3%
34,62
1 092 226 USD 		31 549 +5.3% 34,62 1 092 226 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
18 055 +3.1%
33,71
608 634 USD 		18 055 +3.1% 33,71 608 634 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
3 866 +0.7%
32,47
125 529 USD 		3 866 +0.7% 32,47 125 529 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
4 125 +0.7%
31,86
131 423 USD 		4 125 +0.7% 31,86 131 423 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
2 654 +0.5%
31,00
82 274 USD 		2 654 +0.5% 31,00 82 274 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
29 244 +5.4%
29,42
860 358 USD 		29 244 +5.4% 29,42 860 358 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
31 028 +6.1%
28,82
894 227 USD 		31 028 +6.1% 28,82 894 227 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
36 747 +7.8%
27,70
1 017 892 USD 		36 747 +7.8% 27,70 1 017 892 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
15 243 +3.3%
26,66
406 378 USD 		15 243 +3.3% 26,66 406 378 USD
2024-01-30 2024-01-26 A Achat

Cormorant Asset Management, LP

Actionnaire important
14 388 +3.3%
25,73
370 203 USD 		14 388 +3.3% 25,73 370 203 USD
2022-08-12 2022-08-10 A Achat

Millian Craig Stuart

Chief Operating Officer

Dirigeant
5 000 +22.7%
0,25
1 273 USD 		5 000 +22.7% 0,25 1 273 USD
2022-08-11 2022-08-10 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
3 800 +4.0%
0,26
1 003 USD 		3 800 +4.0% 0,26 1 003 USD
2022-08-10 2022-08-10 A Achat

Moran Sean F.

Chief Financial Officer

Dirigeant
20 000 +11.2%
0,26
5 198 USD 		20 000 +11.2% 0,26 5 198 USD
2022-05-16 2022-05-16 A Achat

Moran Sean F.

Chief Financial Officer

Dirigeant
12 000 +7.2%
0,30
3 600 USD 		12 000 +7.2% 0,30 3 600 USD
2022-05-16 2022-05-16 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
10 500 +12.5%
0,25
2 625 USD 		10 500 +12.5% 0,25 2 625 USD
2022-03-11 2022-03-10 A Achat

Millian Craig Stuart

Chief Operating Officer

Dirigeant
10 000 +83.3%
0,37
3 700 USD 		10 000 +83.3% 0,37 3 700 USD
2022-03-10 2022-03-10 A Achat

Moran Sean F.

Chief Financial Officer

Dirigeant
15 000 +9.9%
0,37
5 550 USD 		15 000 +9.9% 0,37 5 550 USD
2022-03-09 2022-03-09 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
8 600 +11.4%
0,37
3 182 USD 		8 600 +11.4% 0,37 3 182 USD
2020-12-22 2020-12-21 VP Vente planifiée

Moran Sean F.

Chief Financial Officer

Dirigeant
87 500 -20.0%
1,75
153 125 USD 		87 500 -20.0% 1,75 153 125 USD
2020-12-22 2020-12-18 VP Vente planifiée

Moran Sean F.

Chief Financial Officer

Dirigeant
53 610 -13.3%
1,40
75 054 USD 		53 610 -13.3% 1,40 75 054 USD
2020-12-18 2020-12-16 VP Vente planifiée

Moran Sean F.

Chief Financial Officer

Dirigeant
36 923 -9.6%
1,32
48 628 USD 		36 923 -9.6% 1,32 48 628 USD
2020-11-12 2020-11-11 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
4 240 +6.0%
1,21
5 126 USD 		4 240 +6.0% 1,21 5 126 USD
2020-03-18 2020-03-17 A Achat

White Barbara

Chief Medical Officer

Dirigeant
15 606 +8.2%
3,63
56 650 USD 		15 606 +8.2% 3,63 56 650 USD
2020-03-18 2020-03-17 A Achat

Millian Craig Stuart

Chief Commercial Officer

Dirigeant
2 000 +20.0%
4,25
8 500 USD 		2 000 +20.0% 4,25 8 500 USD
2020-03-18 2020-03-17 A Achat

Discordia Robert Paul

Chief Operating Officer

Dirigeant
2 840 +8.7%
3,54
10 054 USD 		2 840 +8.7% 3,54 10 054 USD
2020-03-17 2020-03-17 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
4 300 +6.4%
3,49
15 007 USD 		4 300 +6.4% 3,49 15 007 USD
2019-11-13 2019-11-12 A Achat

White Barbara

Chief Medical Officer

Dirigeant
3 424 +1.8%
4,38
14 992 USD 		3 424 +1.8% 4,38 14 992 USD
2019-11-12 2019-11-12 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 430 +2.2%
4,26
6 092 USD 		1 430 +2.2% 4,26 6 092 USD
2019-11-12 2019-11-11 A Achat

Millian Craig Stuart

Chief Commercial Officer

Dirigeant
1 000 +11.1%
4,38
4 380 USD 		1 000 +11.1% 4,38 4 380 USD
2019-11-12 2019-11-11 A Achat

Discordia Robert Paul

Chief Operating Officer

Dirigeant
2 500 +8.3%
4,62
11 559 USD 		2 500 +8.3% 4,62 11 559 USD
2019-08-16 2019-08-15 A Achat

Millian Craig Stuart

Chief Commercial Officer

Dirigeant
1 500 +20.0%
5,48
8 213 USD 		1 500 +20.0% 5,48 8 213 USD
2019-08-13 2019-08-12 A Achat

White Barbara

Chief Medical Officer

Dirigeant
1 639 +0.9%
6,10
9 998 USD 		1 639 +0.9% 6,10 9 998 USD
2019-08-13 2019-08-12 A Achat

Millian Craig Stuart

Chief Commercial Officer

Dirigeant
1 500 +25.0%
6,00
9 000 USD 		1 500 +25.0% 6,00 9 000 USD
2019-08-12 2019-08-12 A Achat

Discordia Robert Paul

Chief Operating Officer

Dirigeant
15 000 +99.0%
5,86
87 894 USD 		15 000 +99.0% 5,86 87 894 USD
2019-08-12 2019-08-12 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 175 +1.8%
6,06
7 116 USD 		1 175 +1.8% 6,06 7 116 USD
2019-05-20 2019-05-17 A Achat

White Barbara

Chief Medical Officer
1 389 +0.8%
7,20
10 001 USD 		1 389 +0.8% 7,20 10 001 USD
2019-05-15 2019-05-14 A Achat

Millian Craig Stuart

Chief Commercial Officer
1 000 +20.0%
7,23
7 227 USD 		1 000 +20.0% 7,23 7 227 USD
2019-05-14 2019-05-14 A Achat

Moran Sean F.

Chief Financial Officer
100 +0.0%
7,12
712 USD 		100 +0.0% 7,12 712 USD
2019-05-14 2019-05-13 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
995 +1.6%
6,99
6 955 USD 		995 +1.6% 6,99 6 955 USD
2019-03-18 2019-03-15 A Achat

Hochman David P

2 000 +40.0%
6,98
13 958 USD 		2 000 +40.0% 6,98 13 958 USD
2019-03-15 2019-03-15 A Achat

Jenkins John Kenneth

Administrateur non-exécutif
1 000 +inf%
6,98
6 978 USD 		1 000 +inf% 6,98 6 978 USD
2019-03-15 2019-03-14 A Achat

Millian Craig Stuart

Chief Commercial Officer

Dirigeant
5 000 +inf%
6,85
34 259 USD 		5 000 +inf% 6,85 34 259 USD
2019-03-14 2019-03-14 A Achat

Moran Sean F.

Chief Financial Officer

Dirigeant
1 500 +0.4%
6,67
10 005 USD 		1 500 +0.4% 6,67 10 005 USD
2019-03-14 2019-03-14 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 530 +2.5%
6,49
9 930 USD 		1 530 +2.5% 6,49 9 930 USD
2019-03-14 2019-03-14 A Achat

White Barbara

Chief Medical Officer

Dirigeant
4 638 +2.6%
6,47
29 994 USD 		4 638 +2.6% 6,47 29 994 USD
2018-05-16 2018-05-15 A Achat

White Barbara

Chief Medical Officer

Dirigeant
2 586 +1.5%
5,87
15 174 USD 		2 586 +1.5% 5,87 15 174 USD
2018-05-16 2018-05-15 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 725 +2.9%
5,85
10 091 USD 		1 725 +2.9% 5,85 10 091 USD
2018-05-15 2018-05-15 A Achat

Moran Sean F.

Chief Financial Officer

Dirigeant
4 000 +1.2%
5,77
23 080 USD 		4 000 +1.2% 5,77 23 080 USD
2018-05-15 2018-05-14 A Achat

Hochman David P

Administrateur non-exécutif
5 000 +inf%
5,48
27 375 USD 		5 000 +inf% 5,48 27 375 USD
2018-03-15 2018-03-14 A Achat

Hochman David P

5 000 +2.3%
6,67
33 325 USD 		5 000 +2.3% 6,67 33 325 USD
2018-03-15 2018-03-14 A Achat

White Barbara

Chief Medical Officer
2 885 +1.7%
6,89
19 878 USD 		2 885 +1.7% 6,89 19 878 USD
2018-03-15 2018-03-14 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 160 +2.0%
6,89
7 987 USD 		1 160 +2.0% 6,89 7 987 USD
2018-03-14 2018-03-14 A Achat

Moran Sean F.

Chief Financial Officer
3 100 +0.9%
6,60
20 460 USD 		3 100 +0.9% 6,60 20 460 USD
2017-11-17 2017-11-16 A Achat

Panayiotopoulos Paris

14 285 +inf%
7,03
100 392 USD 		14 285 +inf% 7,03 100 392 USD
2017-11-16 2017-11-15 A Achat

Hochman David P

5 000 +2.3%
6,55
32 750 USD 		5 000 +2.3% 6,55 32 750 USD
2017-11-13 2017-11-10 A Achat

Hochman David P

10 000 +2.2%
7,08
70 800 USD 		10 000 +2.2% 7,08 70 800 USD
2017-11-13 2017-11-10 A Achat

Cohen Yuval

Chief Executive Officer

Administrateur exécutif
1 000 +1.7%
7,17
7 169 USD 		1 000 +1.7% 7,17 7 169 USD
2017-11-13 2017-11-10 A Achat

Moran Sean F.

Chief Financial Officer
1 500 +0.4%
7,04
10 560 USD 		1 500 +0.4% 7,04 10 560 USD
2017-11-13 2017-11-10 A Achat

White Barbara

Chief Medical Officer
2 836 +1.7%
7,00
19 852 USD 		2 836 +1.7% 7,00 19 852 USD
2017-08-11 2017-08-11 A Achat

White Barbara

Chief Medical Officer
2 479 +1.5%
6,05
14 998 USD 		2 479 +1.5% 6,05 14 998 USD